Exosome therapy is where regenerative medicine's future is being written — and where the most aggressive marketing lives. Patients deserve straight answers. This FAQ is written to give them.
Case walkthrough: post-CO₂ resurfacing recovery
Priya, 47, undergoes fractional CO₂ resurfacing for photodamage and mild rhytides. Her clinician applies a MISEV-compliant exosome serum topically at the end of the procedure and again at 24 hours. Re-epithelialization completes at day 4 instead of the expected day 6–7; erythema resolves by day 10. Follow-up photos at 3 months show excellent remodeling with no post-inflammatory hyperpigmentation. Exosomes did not do the resurfacing — they made the recovery smoother, which is exactly the honest positioning of the modality today.
Twenty questions patients ask
1. What are exosomes?
Tiny signaling packets released by cells that carry proteins, growth factors, and genetic messengers. They deliver messages between cells and can be harvested from cultured stem cells for therapeutic use.
2. Are they stem cells?
No. Exosomes are released by cells but contain no living cells themselves.
3. Are they FDA approved?
Not for therapeutic injectable use. Topical and post-procedure applications operate within different framings. Any provider claiming FDA-approved injectable exosome therapy is misrepresenting the product.
4. Are they safe?
Topical and open-channel applications from characterized, MISEV-compliant products have a favorable safety profile in reported use. Injectable exosome therapy carries unknown long-term risk.
5. Where do exosomes come from?
Cultured stem cells — typically from umbilical cord, placenta, adipose, or bone marrow sources. Some are platelet-derived (autologous).
6. Are they ethical?
Perinatal source tissue is donated after healthy full-term births, comparable to amniotic biologic sourcing. Autologous platelet exosomes come from your own blood.
7. What can exosomes do well?
Aesthetic skin quality improvement, hair loss support, post-procedure recovery, and research-supported wound care adjuncts.
8. What should I be skeptical of?
Anti-aging IV infusions, cognitive enhancement claims, systemic disease reversal, anti-inflammatory panaceas — these outrun the evidence and the regulatory framing.
9. Does it hurt?
Topical application: no. Post-microneedling or post-infusion: comparable to the primary procedure.
10. Any downtime?
None from the exosome itself; recovery follows the primary procedure.
11. How many sessions do I need?
Aesthetic: 3–4 initial sessions monthly, then quarterly maintenance.
12. When will I see results?
Skin glow within days, meaningful skin quality change at 4–6 weeks, peak at 12 weeks.
13. How much does it cost?
Aesthetic sessions: $500–$1,500 depending on product, delivery, and region.
14. Is it covered by insurance?
No.
15. Can it be combined with PRP or filler?
With PRP: complementary, often better together for aesthetics and hair loss. With filler: allow 2 weeks between procedures.
16. How is it different from PRP?
PRP is your own blood, richer in growth factor variety but variable in concentration. Exosomes are cell-derived vesicles with defined dosing when properly characterized.
17. What is MISEV?
The international consensus standard for what a legitimate exosome product should demonstrate — particle count, size distribution, marker positivity, contaminant exclusion. Ask your provider if their product meets it.
18. What are red flags?
Claims of FDA approval for injection, refusal to share MISEV data, marketing of systemic anti-aging, or unusually low prices that suggest un-characterized product.
19. Can I have exosomes if I am pregnant or breastfeeding?
Typically deferred.
20. What questions should I ask a provider?
Which supplier and product line do you use? Is it MISEV 2023 characterized? How is it stored and handled? What framing do you use for the treatment — topical, adjunct, research use? What outcomes do you track? A good provider will answer all of these clearly.